サマリー

免疫抑制剤の世界市場 2022-2026 年
Technavioは免疫抑制剤市場を監視しており、2022-2026年の間に6.99億ドル、予測期間中にCAGR7.73％で加速して成長すると予測しています。当レポートでは、免疫抑制剤市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25社のベンダーを網羅したベンダー分析などを提供しています。
現在の世界市場のシナリオ、最新動向とドライバー、市場全体の環境に関する最新の分析を提供しています。腎臓移植の償還政策、自己免疫疾患の増加、交通事故の増加などが市場を牽引しています。
免疫抑制剤市場の分析には、薬物クラスと地理的状況も含まれます。
Technavioの免疫抑制剤市場は以下のようにセグメント化されています。
薬物クラス別
- 副腎皮質ホルモン（コルチコステロイド
- モノクローナル抗体
- その他
地域別状況
- 北アメリカ
- 欧州
- アジア
- その他の地域 (ROW)
本調査では、腎移植における免疫抑制剤への依存度の高さが、今後数年間における免疫抑制剤市場の成長を促進する主要な理由の1つであると見ています。また、インプラントの生成に組織工学を使用することの増加や、発展途上国における可処分所得の増加が、同市場の大きな需要につながると考えられます。
Technavio社は、複数のソースからのデータを調査、合成、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。免疫抑制剤市場に関する当レポートの対象領域は次のとおりです。
- 免疫抑制剤市場のサイジング
- 免疫抑制剤市場の予測
- 免疫抑制剤市場の産業分析
Technavioの強力なベンダー分析は、顧客が市場での地位を向上できるように設計されており、これに沿って、本レポートでは、AbbVie Inc.、Accord Healthcare Ltd.、Astellas Pharma Inc,Belcher Pharmaceuticals LLC、Bristol Myers Squibb Co.、F. Hoffmann La Roche Ltd.、GlaxoSmithKline Plc、Intas Pharmaceuticals Ltd.、Johnson and Johnson、LEO Pharma AS、Livzon Pharmaceutical Group Inc、Novartis AG、Pfizer Inc、RPG Life Sciences Ltd、Sanofi、Sebra Pharmaceuticals Inc、TFF Pharmaceuticals Inc、Viatris Inc.などの主要ベンダーが含まれます。また、免疫抑制剤市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含む一次情報および二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/immunosuppressants-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細なイメージを提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果である。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法および分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Drug Class
o Exhibit 06: Executive Summary - Chart on Incremental Growth
o Exhibit 07: Executive Summary - Data Table on Incremental Growth
o Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
• 5 Market Segmentation by Drug Class
o 5.1 Market segments
o Exhibit 24: Chart on Drug Class - Market share 2021-2026 (%)
o Exhibit 25: Data Table on Drug Class - Market share 2021-2026 (%)
o 5.2 Comparison by Drug Class
o Exhibit 26: Chart on Comparison by Drug Class
o Exhibit 27: Data Table on Comparison by Drug Class
o 5.3 Corticosteroids - Market size and forecast 2021-2026
o Exhibit 28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
o 5.4 Monoclonal antibodies - Market size and forecast 2021-2026
o Exhibit 32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
o 5.5 Others - Market size and forecast 2021-2026
o Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Drug Class
o Exhibit 40: Market opportunity by Drug Class ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America - Market size and forecast 2021-2026
o Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
o 7.4 Europe - Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
o 7.5 Asia - Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
o 7.7 US - Market size and forecast 2021-2026
o Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
o 7.8 Germany - Market size and forecast 2021-2026
o Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
o 7.9 China - Market size and forecast 2021-2026
o Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
o 7.10 UK - Market size and forecast 2021-2026
o Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
o 7.11 Canada - Market size and forecast 2021-2026
o Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Astellas Pharma Inc.
o Exhibit 89: Astellas Pharma Inc. - Overview
o Exhibit 90: Astellas Pharma Inc. - Product / Service
o Exhibit 91: Astellas Pharma Inc. - Key news
o Exhibit 92: Astellas Pharma Inc. - Key offerings
o 10.4 Bristol Myers Squibb Co.
o Exhibit 93: Bristol Myers Squibb Co. - Overview
o Exhibit 94: Bristol Myers Squibb Co. - Product / Service
o Exhibit 95: Bristol Myers Squibb Co. - Key offerings
o 10.5 F. Hoffmann La Roche Ltd.
o Exhibit 96: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 97: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 98: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 99: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 100: F. Hoffmann La Roche Ltd. - Segment focus
o 10.6 GlaxoSmithKline Plc
o Exhibit 101: GlaxoSmithKline Plc - Overview
o Exhibit 102: GlaxoSmithKline Plc - Business segments
o Exhibit 103: GlaxoSmithKline Plc - Key news
o Exhibit 104: GlaxoSmithKline Plc - Key offerings
o Exhibit 105: GlaxoSmithKline Plc - Segment focus
o 10.7 Intas Pharmaceuticals Ltd.
o Exhibit 106: Intas Pharmaceuticals Ltd. - Overview
o Exhibit 107: Intas Pharmaceuticals Ltd. - Product / Service
o Exhibit 108: Intas Pharmaceuticals Ltd. - Key offerings
o 10.8 Johnson and Johnson
o Exhibit 109: Johnson and Johnson - Overview
o Exhibit 110: Johnson and Johnson - Business segments
o Exhibit 111: Johnson and Johnson - Key news
o Exhibit 112: Johnson and Johnson - Key offerings
o Exhibit 113: Johnson and Johnson - Segment focus
o 10.9 Novartis AG
o Exhibit 114: Novartis AG - Overview
o Exhibit 115: Novartis AG - Business segments
o Exhibit 116: Novartis AG - Key offerings
o Exhibit 117: Novartis AG - Segment focus
o 10.10 Pfizer Inc.
o Exhibit 118: Pfizer Inc. - Overview
o Exhibit 119: Pfizer Inc. - Product / Service
o Exhibit 120: Pfizer Inc. - Key news
o Exhibit 121: Pfizer Inc. - Key offerings
o 10.11 Sanofi
o Exhibit 122: Sanofi - Overview
o Exhibit 123: Sanofi - Business segments
o Exhibit 124: Sanofi - Key news
o Exhibit 125: Sanofi - Key offerings
o Exhibit 126: Sanofi - Segment focus
o 10.12 Viatris Inc.
o Exhibit 127: Viatris Inc. - Overview
o Exhibit 128: Viatris Inc. - Business segments
o Exhibit 129: Viatris Inc. - Key offerings
o Exhibit 130: Viatris Inc. - Segment focus
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 131: Inclusions checklist
o Exhibit 132: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 133: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 134: Research methodology
o Exhibit 135: Validation techniques employed for market sizing
o Exhibit 136: Information sources
o 11.5 List of abbreviations
o Exhibit 137: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Drug Class - Market share 2021-2026 (%)
Exhibits25: Data Table on Drug Class - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Drug Class
Exhibits27: Data Table on Comparison by Drug Class
Exhibits28: Chart on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Corticosteroids - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Corticosteroids - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Monoclonal antibodies - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Monoclonal antibodies - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits40: Market opportunity by Drug Class ($ million)
Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits44: Chart on Geographic comparison
Exhibits45: Data Table on Geographic comparison
Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Market opportunity By Geographical Landscape ($ million)
Exhibits83: Impact of drivers and challenges in 2021 and 2026
Exhibits84: Overview on Criticality of inputs and Factors of differentiation
Exhibits85: Overview on factors of disruption
Exhibits86: Impact of key risks on business
Exhibits87: Vendors covered
Exhibits88: Matrix on vendor position and classification
Exhibits89: Astellas Pharma Inc. - Overview
Exhibits90: Astellas Pharma Inc. - Product / Service
Exhibits91: Astellas Pharma Inc. - Key news
Exhibits92: Astellas Pharma Inc. - Key offerings
Exhibits93: Bristol Myers Squibb Co. - Overview
Exhibits94: Bristol Myers Squibb Co. - Product / Service
Exhibits95: Bristol Myers Squibb Co. - Key offerings
Exhibits96: F. Hoffmann La Roche Ltd. - Overview
Exhibits97: F. Hoffmann La Roche Ltd. - Business segments
Exhibits98: F. Hoffmann La Roche Ltd. - Key news
Exhibits99: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits100: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits101: GlaxoSmithKline Plc - Overview
Exhibits102: GlaxoSmithKline Plc - Business segments
Exhibits103: GlaxoSmithKline Plc - Key news
Exhibits104: GlaxoSmithKline Plc - Key offerings
Exhibits105: GlaxoSmithKline Plc - Segment focus
Exhibits106: Intas Pharmaceuticals Ltd. - Overview
Exhibits107: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits108: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits109: Johnson and Johnson - Overview
Exhibits110: Johnson and Johnson - Business segments
Exhibits111: Johnson and Johnson - Key news
Exhibits112: Johnson and Johnson - Key offerings
Exhibits113: Johnson and Johnson - Segment focus
Exhibits114: Novartis AG - Overview
Exhibits115: Novartis AG - Business segments
Exhibits116: Novartis AG - Key offerings
Exhibits117: Novartis AG - Segment focus
Exhibits118: Pfizer Inc. - Overview
Exhibits119: Pfizer Inc. - Product / Service
Exhibits120: Pfizer Inc. - Key news
Exhibits121: Pfizer Inc. - Key offerings
Exhibits122: Sanofi - Overview
Exhibits123: Sanofi - Business segments
Exhibits124: Sanofi - Key news
Exhibits125: Sanofi - Key offerings
Exhibits126: Sanofi - Segment focus
Exhibits127: Viatris Inc. - Overview
Exhibits128: Viatris Inc. - Business segments
Exhibits129: Viatris Inc. - Key offerings
Exhibits130: Viatris Inc. - Segment focus
Exhibits131: Inclusions checklist
Exhibits132: Exclusions checklist
Exhibits133: Currency conversion rates for US$
Exhibits134: Research methodology
Exhibits135: Validation techniques employed for market sizing
Exhibits136: Information sources
Exhibits137: List of abbreviations